Lipid peroxidation and antioxidant enzyme activities in vascular and alzheimer dementias

Neurochemical Research

Volumn 33, Issue 3, 2008, Pages 450-458

  Casado, Ángela ^a   Encarnacion Lopez Fernandez Ma ^a   Concepcion Casado Ma ^b   De La Torre, Rosario ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b Centro de Salud INSALUD   (Spain)

Author keywords

Antioxidant enzymes; Catalase; Dementia of the Alzheimer type; Glutathione peroxidase; Glutathione reductase; Lipid peroxidation; Malondialdehyde; Oxidative stress; Superoxide dismutase; Vascular dementia

Indexed keywords

CATALASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; BRAIN DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANTIOXIDANTS; CATALASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMENTIA, VASCULAR; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; SPECTROPHOTOMETRY, ULTRAVIOLET; SUPEROXIDE DISMUTASE;

EID: 38949123654     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9453-3     Document Type: Article

References (52)

1. Terry RD (1994) Neuropathological changes in Alzheimer's disease. Prog Brain Res 101:383-390
2. Christie JE, Whalley LJ, Bennie J et al (1987) Characteristic plasma hormone changes in Alzheimer's disease. Br J Psychiatry 150:674-681
3. Meyer JS, McClintic KL, Rogers RL et al (1988) Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 51:1489-1497
4. Román GC (2002) Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am 86:477-499
5. Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer's disease. Neurobiol Aging. 21(3):383-421
6. Zhu X, Raina AK, Lee HG et al (2004) Oxidative stress signaling in Alzheimer's disease. Brain Res 1000:32-39
7. Bowling AC, Beal MF (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56:1151-1171
8. Siesjo BK (1992) Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanism of damage and treatment. J Neurosurg 77:337-354
9. Reiter RJ (1995) Oxidative processes and oxidative defense mechanism in the aging brain. FASEB J 9:526-533
10. Halliwell B (1989) Oxidants and the central nervous system: some fundamental questions. Acta Neurol Scand 126:23-33
11. Slater TF (1984) Overview of the methods used for detecting lipid peroxidation. In: Packer L (ed) Methods in enzymology, oxygen radicals in biological systems, vol. 105. London Academic Press, pp 283-293
12. Draper HH, Dhanakoti SN, Hadley M et al (1988) Malondialdehyde in biological systems. In: Chow CK (ed) Cellular antioxidant defense mechanism. CRC Press, Boca Raton, pp 97-100
13. Ambrosio G, Flaherty JJ (1991) Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused heart. J Clin Invest 87:2056-2066
14. Michel C, Raes M, Toussaint O et al (1994) Importance of Se-glutathione peroxidase, catalase and Cu/Zn SOD for cell survival against oxidative stress. Free Radic Biol Med 17:235-248
15. Sun AY, Chen YM (1985) Oxidative stress and neurodegenerative disorders. J Biomed Sci 5:401-414
16. McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer's disease: report of the NICDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
17. Roth M, Tym E, Mountjoy CQ et al (1986) CAMDEX: a standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709
18. Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260
19. Minami M, Yoshikawa H (1979) A simplified assay method of superoxide dismutase activity for clinical use. Clin Chem Acta 92:337-342
20. McCord JM, Fridovich I (1969) Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055
21. Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic Analysis. Weinheim Verlag Chemic, pp 673-676
22. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70-158
23. Carmagnol F, Sinet PM, Jerome H (1983) Selenium-dependent and non-selenium-dependent glutathione peroxidases in human tissue extracts. Biochim Biophys Acta 759:49-57
24. Calberg I, Mannervik J (1985) Glutathione reductase. Methods in enzymology, vol. 113. Academic Press Inc, pp 484-490
25. Bull AW, Marnett LJ (1985) Determination of malondialdehyde by ion-pairing high-performance liquid chromatography. Anal Biochem 149:284-290
26. Esterbauer H, Lang J, Zadravec S et al (1984) Detection of malondialdehyde by high-performance liquid chromatography. In: Packer L (ed) Methods in enzymology: oxygen radical in biological systems, vol. 105. Academic Press, London, pp 319-327
27. De la Torre R, Casado A, López-Fernández ME et al (1999) Superoxide dismutase activity levels in a Spanish population 50-93 years. Am J Hum Biol 11:45-47
28. Casado A, López-Fernández ME (2003) Age-correlated changes of erythrocyte catalase activity in the Spanish population. Gerontology 49:251-54
29. Leutner S, Schindownski K, Frolich L et al (2005) Enhanced ROS-generation in lymphocytes from Alzheimer's disease. Pharmacopsychiatry 38(6):312-315
30. Rinaldi P, Polidori MC, Metastasio A et al (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24(7):915-919
31. Zafrilla P, Mulero J, Xandri JM et al (2006) Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 13:1075-1083
32. Misra HP, Fridovich I (1972) The generation of superoxide radical during the autooxidation of haemoglobin. J Biol Chem 247:6960-6962
33. Perrin R, Briançon S, Jeandel C et al (1990) Blood activity of Cu/Zn superoxide dismutase and catalase in Alzheimer's disease: a case control study. Gerontology 36:306-313
34. de Lusting ES, Serra JA, Kohan S et al (1993) Copper-Zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J Neurol 115:18-25
35. De la Torre R, Casado A, López-Fernández ME et al (1996) Human aging brain disorders: role of antioxidant enzymes. Neurochem Res 21:885-888
36. Richardson JS (1993) Free radicals in the genesis of Alzheimer's disease. Ann NY Acad Sci 695:73-76
37. Chen L, Richardson JS, Cadwell JE et al (1994) Regional brain activity of free radical defense enzyme in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int J Neurosci 75:83-90
38. Ihara Y, Hayabara T, Sasaki K et al (1997) Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J Neurol Sci 153:76-81
39. Venarucci D, Venarucci V, Vallese A et al (1991) Free radicals: important cause of pathologies refer to ageing. Panminerva Med 41:335-339
40. Serra JA, Marschoff ER, Dominguez RO et al (2004) Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by concomitant Type II diabetes mellitus condition. J Neurol Sci 218:17-24
41. Jeandel C, Nicolas MB, Dubois F et al (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35:275-282
42. Anneren G, Gardner A, Lundin T (1986) Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer type. Acta Neurol Scand 73:586-589
43. Foy CJ, Passmore AP, Vahidassr MD et al (1999) Plasma chain-breakingantioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. Q F Med 92:39-45
44. Guidi I, Galimberti D, Lonati S et al (1999) Oxidative imbalance in patients with mild impairment and Alzheimer's disease. Neurobiol Aging 2006 27:262-269
45. Praticò D, Sung S (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6:171-175
46. Mariani E, Polidori MC, Cherubine A et al (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr 827:65-75
47. Foster TC (2006) Biological markers of age-related memory deficits: treatment of senescent physiology. CNS Drugs 20(2):153-156
48. Zandi PP, Anthony JC, Khachaturian AS et al (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 61(1):82-88
49. Morris MC, Evans DA, Bienias JL et al (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287(24):3230-3237
50. Bermejo P, Gomez-Serranillos P, Santos J et al (1997) Determination of Malonaldehyde in Alzheimer's disease: a comparative study of high-performance liquid chromatography and tiobarbituric acid test. Gerontology 43:218-222
51. Gil P, Fariñas F, Casado A et al (2002) Malondialdehyde: a possible marker of ageing. Gerontology 48:209-214
52. Mariani E, Cornacchiola V, Polidori MC et al (2006) Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status: Results from the Zincage Project. Biogerontology 7(5-6):391-398